surmount tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT-OSA Trial Results and Potential

(2012) Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, doubleblind pilot study

Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved

This may reflect the absence of effect of DPP-4 on GE or the higher circulating concentrations of GLP-1 observed in PAM carriers may augment the effect of DPP-4i in prolonging the half-life of GLP-1, which may off set the expected GLP-1 resistance [55]

Musculoskeletal: Tendon, ligament, and muscle injury recovery protocols in rodent models

That is what I was talking about